Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials | Leukemia
TreRNA is associated with progression-free survival in CLL. a.... | Download Scientific Diagram
Kaplan-Meier survival curve for the whole CLL series. | Download Scientific Diagram
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy | Haematologica
IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling | PNAS
Overall survival benefit of symptom monitoring in real-world patients with chronic lymphocytic leukaemia treated with ibrutinib: a FiLO group study - European Journal of Cancer
OVERALL SURVIVAL BENEFIT OF OBINUTUZUMAB OVER RITUXIMAB WHEN.... EHA Library. Goede V. Jun 15 2018; 215923
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center
National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population‐based data - Lenartova - 2016 - Cancer Medicine - Wiley Online Library
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology
Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China
Immune failure, infection and survival in chronic lymphocytic leukemia | Haematologica
THE CHRONIC LYMPHOCYTIC LEUKEMIA-INTERNATIONAL PROGNOSTIC INDEX.... EHA Library. A. Parikh S. Jun 12 2020; 294608
Ibrutinib vs FCR: does order of therapy matter? - CLL Support
Overall survival of CLL-IPI risk groups. | Download Scientific Diagram
New Survival Estimates in Patients with CLL or SLL: RS5 as a Prognostic Tool? - Advances in Lymphoma
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm | SpringerLink
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia | Journal of Translational Medicine | Full
VENCLEXTA® (venetoclax tablets) | Additional Follow-up Data for CLL/SLL
4.13 Proposal of a New Prognostic Score for Previously Untreated Patients with Chronic Lymphocytic Leukemia Based on an Overall Survival Analysis of Three German CLL Study Group Phase III Trials - Clinical
ex998to8k07380a_11072013.htm
Chronic lymphocytic leukemia Prognosis and treatment Emili Montserrat Institute of Hematology and Oncology. University of Barcelona ESH - Hammamet, ppt download
A) Overall survival (OS) and (B) Chronic Lymphocytic Leukemia... | Download Scientific Diagram
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study | Haematologica
Overall survival according to disease stage in CLL patients. (This... | Download Scientific Diagram
Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations | NEJM
Overall survival (OS) analysis of CLL patients using the qChip®Hemo... | Download Scientific Diagram
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia - ScienceDirect
